Manifold, an AI-enabled scientific analysis platform, introduced 5 new appointments to its management workforce and two new members of its advisory workforce.
Chris McMahon joins the corporate as chief individuals officer, Alex Akersd as vp of development, Danielle Kowalski as vp of authorized, Megan Ahigian as senior director of product and partnerships and Taylor Gleason as senior director of selling.
McMahon, Ahigian and Gleason beforehand held related roles at Kyruus Health, Akers served as VP of gross sales at Health Catalyst and Kowalski was VP and deputy normal counsel of HubSpot’s authorized and compliance perform.
Mike Longo and Chris Reisig will be part of the corporate as go-to-market advisors. Longo beforehand labored as Veeva’s vp of analysis and growth in North America.
“We’re thrilled to welcome a number of the business’s strongest leaders to assist us remodel scientific examine and information operations with our AI-powered platform,” mentioned Vinay Seth Mohta, CEO and Co-Founding father of Manifold. “Our workforce shall be essential to rising our partnerships and increasing our options – attaining our imaginative and prescient of constructing it ten occasions sooner and one-tenth the associated fee to hold out trendy research and analytics.”
Healthcare information firm ConcertAI introduced Dhiraj Carumbay has been appointed senior vp and normal supervisor of the corporate’s TeraRecon enterprise.
Carumbay managed enterprise models at RadNet, Amazon AWS, Philips Healthcare, Fujifilm, and GE HealthCare. At AWS, he oversaw Amazon’s cloud options for the healthcare and life sciences industries. Previous to that, he held enterprise management and world product roles at GE HealthCare.
“Dhiraj began his profession centered on diagnostic imaging and immediately operating healthcare supplier options utilizing AI – that was the important thing criterion we had for this management position,” Jeff Elton, CEO of ConcertAI, mentioned in an announcement.
“His depth in imaging broadly, SaaS applied sciences, and AI, he’s uniquely suited to make sure our supplier and biopharma companions have probably the most superior applied sciences and information to rework the diagnostic and analysis expertise.”
